Lv1
10 积分 2023-10-29 加入
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
2个月前
已完结
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
4个月前
已完结
Torikai H, Reik A, Liu P-Q, et al. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood. 2012;119(24):5697-5705
4个月前
已关闭
Torikai H, Reik A, Liu P-Q, et al. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood. 2012;119(24):5697-5705
4个月前
已关闭
Torikai H, Reik A, Liu P-Q, et al. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood. 2012;119(24):5697-5705
4个月前
已关闭
Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells ‘off the shelf’?
4个月前
已完结
皖公网安备34019202002308
